Azghani, ann buchanan, jake boren, timothy allen, najib m. Intrapleural fibrinolytic agents, especially urokinase, are safe, costeffective means of facilitating complete chest tube drainage, thereby avoiding the morbidity of a major thoracotomy for 77%. Intrapleural tpa and dnase in pleural infection n engl j med 365. Intrapleural fibrinolytic therapy in a neonate intrapleural fibrinolytic therapy in a neonate narayan prasad, amarendra 20110901 00. Cerebral gas embolism caused by pleural fibrinolytic. Cerebral air embolism is an unusual potentially severe complication of this technique.
Intrapleural fibrinolytic treatment of pleural space sepsis was first described in 1949 when tillett and sherry published their seminal article on this subject using streptokinase. Because few studies have evaluated its safety and effectiveness, we conducted a retrospective cohort study of outcomes after tpa treatment during a 10year period at our institution. Intrapleural fibrinolytic therapy in patients with. Medical thoracoscopy versus intrapleural fibrinolytic. Discordance between the negative largest trial of this therapy and other studies is of concern, however, as is an absence. The natural history of a complicated parapneumonic effusion is to develop a single loculus or multiple loculations and then progress to an empyema cavity in untreated or inadequately treated. To assess the safety and efficacy of urokinase and alteplase for intrapleural fibrinolysis in children with parapneumonic pleural fluid collections. Intrapleural fibrinolytic therapy in the management of. Pleural effusions are common complications of pediatric bacterial pneumonias. Reperfusion therapy for acute myocardial infarction. Intrapleural urokinase versus normal saline in the treatment of complicated parapneumonic effusions and empyema. Intrapleural fibrinolytic therapy for treatment of. Fibrinolytic therapy was a major advance in the treatment of acute stemi since 90% of stemi is due to plaque rupture and subsequent thrombus formation remains a viable option for reperfusion therapy due to the limited availability of primary pci therapy.
Rahman2,3 1the department of cellular and molecular biology and the texas lung injury institute, the university of texas health science center at tyler, tyler, texas. Emp generally occurs with pleural loculation and impaired drainage is often treated with intrapleural fibrinolytic therapy ipft or surgery. The intrapleural therapy will be given twice daily for a maximum of 6 doses. In our clinic, we used intrapleural fibrinolytic agents in 72 pediatric patients with multiloculated empyema between 1994 and 2002. Intrapleural fibrinolysis for parapneumonic effusion and. To avoid a thoracotomy yet treat this difficult problem, intrapleural fibrinolytic agents were employed. Intrapleural use of tissue plasminogen activator and dnase in. However, the routine use of fibrinolytic therapy cannot be recommended because the trial numbers were too small. Given the high patient surgical risks inherent to his comorbidities, combined intrapleural therapy cit was started using a protocol similar to that explained by rahman et al.
The fibrinolytic therapy was given via the intrapleural catheter 814 fr or chest tube 2832 fr that was placed by interventional radiology, respirology or thoracic surgery, after which the tube was clamped for 2 h and then unclamped and placed under suction of. Pdf the efficacy of vats and intrapleural fibrinolytic. Between april 1, 1990, and april 1, 1993, consecutive patients presenting with a fibrinopurulent empyema were demonstrated to have incomplete. Intrapleural fibrinolytic therapy ipft in loculated. Fibrinolytic treatment of complicated pediatric thoracic. Intrapleural instillation of fibrinolytic agents for treatme.
Addition of dornase to intrapleural fibrinolytic therapy. The dose of intrapleural tpa 2 mg, frequency of administration every 24 hours, and duration of therapy 72 hours, for both patients were selected based on our institutional experience with fibrinolysis for pleural space infections and are consistent with dosing strategies from limited reports of intrapleural fibrinolysis for retained. There are few welldesigned trials in children and most studies are prospective or retrospective observational reports with great diversity in the age of included children, type of fibrinolytic, timing of administration, number of doses, and outcomes evaluated. Intrapleural fibrinolytic therapy for treatment of adult. Author links open overlay panel surinder janda md john swiston md. Intrapleural fibrinolysis during pediatric extracorporeal. Burkholderia pseudomallei, a soil saprophyte typically associated with the highly fatal disease melioidosis in southeast asia, is an increasing globa.
Dose dependency of outcomes of intrapleural fibrinolytic. Active macroglobulin is a reservoir for urokinase after. Intrapleural fibrinolysis for the treatment of indwelling. Although we advocate the continued use of ipft in adult patients with pleural infection, loculation, and failed drainage, a number of controversial points remain. Lifethreatening pleural hemorrhage following intrapleural. Intrapleural fibrinolytic therapy ipft in loculated pleural effusions. The role of dnase in combination with a fibrinolytic or dnase alone in the treatment of empyema will be answered by the recently completed multi. In this issue of jama pediatrics, livingston et al 1 address the important question of whether a therapy demonstrated to improve the care of adult patients with empyema, the addition of dornase alfa dnase to tissue plasminogen activator tpa intrapleural therapy, has similar benefits in children. Failure to control the pleural effusions may lead to progressive disease and can result in complicated parapneumonic effusions. Tissue plasminogen activator tpa has been successfully used to relieve obstruction of dysfunctional devices, including vascular catheters. Rumende, zulkifli amin departement of internal medicine, faculty of medicine, university of indonesia cipto mangunkusumo hospital. Objective to describe the use of intrapleural instillation of fibrinolytic agents as adjunctive therapy for children with complicated pleural effusions and empyema.
Despite this extensive history of use, however, little is known about complications that may arise with the. Intrapleural fibrinolytic therapy is effective for shortening the lengths of hospital stays without increasing the incidence of severe side effects. The patient exhibited increased pulmonary compliance and oxygenation and was successfully separated from ecls four days after completion of tpa. Intrapleural fibrinolytic therapy remains an option for poor surgical candidates who fail chest tube drainage or who require a period of medical stabilization before surgery is performed.
Fibrinolytic therapy can be used for complicated pleural effusions or empyema without the need for operative intervention. Update on the role of intrapleural fibrinolytic therapy in. Intrapleural fibrinolysis, pneumonia, empyema, effusion, vats. Background and purpose intrapleural fibrinolytic therapy is a technique used to treat empyemas and parapneumonic effusions.
Intrapleural fibrinolytic therapy is often used in pediatric empyema, despite limitations with current evidence. To study the factors associated with bleeding postfibrinolytic therapy. Intrapleural fibrinolytic treatment with alteplase tpa and dornase alfa dnase may be considered as an adjunct to medical management in selected patients at the discretion of the respiratory consultant this guideline details the rationale, indications, contraindications and protocol for administering. Emp generally occurs with pleural loculation and impaired drainage is often treated with intrapleural fibrinolytic therapy ipft or. It is currently unclear how the use of intrapleural fibrinolytic therapy should be used in the context of thoracic surgery, however if a patient fails to improve after. During the 72 hours of fibrinolytic therapy, cumulative pleural drainage was 300 ml 15 mlkg and serial chest radiographs confirmed reduced volume of intrapleural hematoma and improved lung aeration. The use of intrapleural fibrinolysis to treat complicated pleural effusions dates back to 1949 when. Intrapleural fibrinolytic therapy for pleural infection.
Intrapleural therapy huggins 2011 respirology wiley. Drainage of infected fluid is key to successful treatment, but intrapleural fibrinolytic therapy did not i. The utility of dnase in adults requiring pleural drainage for. To study the factors associated with failure of therapy. To describe the use of intrapleural fibrinolytic therapy. We studied 97 patients with mpe and a nondraining ipc in the setting of persistent pleural fluid who were treated with intrapleural tpa. Contraindications for intrapleural enzyme therapy are not widely agreed. Intrapleural fibrinolytic treatment of multiloculated. Rahman,4 kathleen koenig,1 mignote chamiso,1 sophia karandashova,1 james henry,1 and steven idell1 1department of cellular and molecular biology of the university of. This stage requires pleural space drainage along with either instillations of intrapleural fibrinolytics or vats apart from appropriate antibiotics. Accepted manuscript 1 intrapleural fibrinolytic therapy for pleural infection 1demosthenes bouros, 1argyris tzouvelekis, 2katerina m. There are multiple reports of successful 88100% efficacy ipft in adult 1, 7. Intrapleural fibrinolytic therapy for empyema and pleural. Intrapleural fibrinolytic therapy in empyema thoracis.
Efficacy of intrapleural instillation of fibrinolytics for. Combined intrapleural therapy in infectious pleural effusion. More recent reports have increased interest in the intrapleural use of e p t novel drugs, singly or in combination with fibrinolytic drugs, that decrease the viscosity of empyema pus to promote drainage1 or interfere with the formation of intrapleural fibrous c e bands 1 2. Fibrinolytic agents are believed to work through decreasing fibrinous strands and reopening pleural pores blocked by fibrinous material. Jun 14, 2011 intrapleural use of a fibrinolytic agent to divide adhesions and dnase to decrease pus viscosity may promote efficient drainage of the empyema. Intrapleural fibrinolytic therapy in a neonate, indian. The present results show that intrapleural fibrinolysis with urokinase may be potentially effective for reducing the need for surgery. Fibrinolytic therapy has recently been used in such patients in an effort to reduce the need for surgical intervention 1,36. The natural history of a complicated parapneumonic effusion is to develop a single loculus or multiple loculations and then progress to an. Contraindications for intrapleural enzyme therapy are not widely agreed upon and little is known. Patients who received intrapleural fibrinolytic therapy for symptomatic loculation between january 1, 2002, and june 30, 2014, were captured retrospectively by interrogation of the mpe, cancer, and pharmacy electronic databases at each center.
The incidence of empyema emp is increasing worldwide. Intrapleural fibrinolytic treatment of multiloculated thoracic empyemas. Rahman2,3 1the department of cellular and molecular biology and the texas lung injury institute, the university of texas health science center. Rahman, kathleen koenig, mignote chamiso, sophia karandashova, james henry, steven idell. The aim of this study is to compare the therapeutic yield of medical thoracoscopy and intrapleural. Summary of case a patient with parapneumonic pleural effusion underwent pleural lavage with streptokinase when he suddenly demonstrated focal. Intrapleural hemorrhage after administration of tpa. All patients who received intrapleural fi brinolytic therapy for symptomatic loculations between january 1, 2002, and june 30, 2014, in four established ipc centers were retrospectively included. Rahman,4 kathleen koenig,1 mignote chamiso,1 sophia karandashova,1 james henry,1 and steven idell1. Fibrinolytic drugs are most likely to be successful in patients with early ppe. Intrapleural fibrinolytic therapy in a neonate request pdf.
Fibrinolytic therapy versus medical thoracoscopy full. Objectives to assess risk factors associated with failure and bleeding in intrapleural fibrinolytic therapy ipft for pleural effusions. Feb 01, 20 the fibrinolytic therapy was given via the intrapleural catheter 814 fr or chest tube 2832 fr that was placed by interventional radiology, respirology or thoracic surgery, after which the tube was clamped for 2 h and then unclamped and placed under suction of. Individual centers audited different time periods depending on the avail. Intrapleural instillation of fibrinolytic agents has been found to be a useful. Intrapleural fibrinolytic therapy ipft in loculated pleural. Intrapleural fibrinolytic enzyme therapy is a potentially surgerysparing treatment for poorly resolving parapneumonic effusion and empyema. Intrapleural fibrinolytic agents, especially urokinase, are safe, costeffective means of facilitating complete chest tube drainage, thereby avoiding the morbidity of. The efficacy of vats and intrapleural fibrinolytic therapy in. Intrapleural fibrinolytic therapy with streptokinase appears to be a safe and effective adjunctive therapy of choice and may have significant benefit even in newborns with complicated.
Perspective intrapleural fibrinolytic therapy for empyema and pleural loculation. Intrapleural use of a fibrinolytic agent to divide adhesions and dnase to decrease pus viscosity may promote efficient drainage of the empyema. Cerebral gas embolism caused by pleural fibrinolytic treatment. Clotbusting drugs for infections of the lining of the. Intrapleural fibrinolytic agents, especially urokinase, are safe, costeffective means of facilitating complete chest tube drainage, thereby avoiding the morbidity of a major thoracotomy for 77% of a group multiloculated empy ema patients who traditionally would have required open surgical therapy. Key messages the importance of imageguided placement of drains and ct. Dose dependency of outcomes of intrapleural fibrinolytic therapy in new rabbit empyema models andrey a. In patients with complicated infective pleural effusion or empyema, intrapleural fibrinolytic therapy was associated with a reduction in the requirement for surgical intervention and overall treatment failure but with no evidence of change in mortality. Despite this extensive history of use, however, little is known about complications that may arise with the use of this therapy.
It is safe in the majority of patients, however the most significant risk associated with this treatment is severe bleeding secondary to pleural hemorrhage. Participants we identified 237 cases that received ipft for the treatment of pleural effusions. Data for 227 patients were compiled including demographics, investigations. Komissarov, 1 galina florova, 1 ali azghani, 3 sophia karandashova, 1 anna k. Update on the role of intrapleural fibrinolytic therapy in the management of complicated parapneumonic effusions and empyema gurmeet singh, ceva w.
Intrapleural fibrinolytic therapy in patients with nondraini. The efficacy of vats and intrapleural fibrinolytic therapy in parapneumonic empyema treatment. Intrapleural fibrinolytic therapy for treatment of adult parapneumonic effusions and empyemas. Intrapleural instillation of fibrinolytic agents for. Azghani,2 ann buchanan,1 jake boren,1 timothy allen,3 najib m.
Fibrinolytic therapy was beneficial for the outcomes of treatment failure surgical intervention or death risk ratio rr, 0. Nov 11, 2019 intrapleural fibrinolytic therapy is often used in pediatric empyema, despite limitations with current evidence. For almost 70 years, intrapleural fibrinolytic therapy ipft has been part of the therapeutic armamentarium to expedite pleural drainage in. Intrapleural fibrinolytic therapy is an option for the management of pleuropneumonia in horses without the need for surgical intervention, which, despite being shown to be of benefit in the treatment of the condition, is expensive and available at only a small number of specialist institutions vachon and fischer 1998. Intrapleural fibrinolytic therapy in the management of septic.
Intrapleural tpa is used by some centers to restore flow of nondraining indwelling pleural catheters ipcs in symptomatic patients with malignant pleural effusions mpes. Pdf intrapleural fibrinolytic therapy for pleural infection. Although we advocate the continued use of ipft in adult patients with pleural infection, loculation, and failed drainage, a. Concurrent tpa and dnase will be administered intrapleurally through the chest tube followed by saline flush. Intrapleural use of tissue plasminogen activator and dnase.
Heffner 1department of pneumonology, medical school, democritus university of thrace, alexandroupolis, greece. Group a 50% of patients were offered the intrapleural administration of fibrinolytic therapy in which 250,000 iu streptokinase over 100 ml normal saline was injected intrapleurally via the thoracostomy tube once daily through six days duration which then was clamped after each session for eight hours asking the patient to change his. Key messages the importance of imageguided placement of drains and ct scan assessment of the loculated collections. Forest plot for outcome of surgical intervention for fibrinolytic therapy vs placebo for loculated pleural effusions only.
Intrapleural administration of fibrinolytic enzymes as an. Although we advocate the continued use of ipft in adult patients with pleural infection. Intrapleural fibrinolytic enzymes have been used for over 60 years in the treatment of complicated pleural effusions to lyse loculations and promote resolution. Intrapleural fibrinolytic therapy in a neonate springerlink. The tube will then be clamped for 120 minutes and after which it will be connected back to wall suction. Setting tertiary care childrens hospital in an academic medical center.
182 1535 285 726 823 802 781 476 1174 987 559 1211 1535 791 1065 1437 1062 1473 1233 1436 1124 469 1226 1231 566 58 317 165 771 487 593 961 1327 1487 608 85 939 897 1099 866 447 879 1046 1385 502 1025 1457 88 1060 475